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There has been a growing interest in the study of epigenetic mechanisms to elucidate
the molecular bases of human brain-related diseases and disorders. Frequently,
researchers utilize post-mortem tissue with the assumption that post-mortem tissue
decay has little or no effect on epigenetic marks. Although previous studies show no
effect of post-mortem interval on certain epigenetic marks, no such research has been
performed on cytosine modifications. In this study, we use DNA from the brains of
adult Sprague Dawley rats subjected to post-mortem intervals at room temperature,
ranging from 0 to 96 h, to assess the stability of cytosine modifications, namely 5-
methycytosine and 5-hydroxymethylcytosine. Our results indicate that neither global nor
site-specific levels of 5-methycytosine and 5-hydroxymethylcytosine are affected by the
post-mortem intervals we studied. As such, the use of post-mortem tissue to study
cytosine modifications in the context of neurological or neuropsychiatric disorders is
appropriate.
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INTRODUCTION
There has been growing interest in the investigation of epigenetic changes associated with disease
states. Among pathological conditions of the brain, post-translational histone modifications, non-
coding RNAs, and cytosine modifications have all been associated with developmental disorders,
neurological diseases, psychiatric illnesses, and cancers, among others.
In particular, 5-methylcytosine (5mC) has been the most widely studied epigenetic modification.
Research has shown 5mC to be central to the establishment of tissue-specific gene expression, cell
differentiation, genomic imprinting, and X-inactivation. Recently, however, interesting research
provided evidence showing that 5mC can be oxidized to 5-hydroxymethylcytosine (5hmC) in
a reaction catalyzed by the ten–eleven translocation (TET) enzymes (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009; Ito et al., 2010). This finding led to the discovery of additional
oxidative products, namely 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). Together,
these oxidative products of 5mC have led to the proposal of active DNA demethylation, where
methylation is removed from a cytosine base by successive oxidations and base excision repair.
Although clues are rapidly emerging, questions still remain on the dynamics of the cytosine
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demethylation pathway and the functions of these intermediate
molecules. Nevertheless, growing evidence points to the
involvement of 5mC and its oxidative products in human
diseases and disorders.
To determine the function of cytosine modifications in
human brain diseases, such as those related to neuropsychiatric,
neurodevelopmental, and neurodegenerative phenotypes, many
researchers must rely on post-mortem brain tissue to conduct
their studies. Typically, post-mortem studies report post-mortem
interval (PMI), which represents the amount of time between
a subject’s death and collection and processing of the brain. It
has previously been shown that DNA is stable across extended
PMIs (Hynd et al., 2003), while the same is true for microRNAs
(miRNAs) and some histone modifications (Huang et al.,
2006; Stan et al., 2006; Nagy et al., 2015). It has also been
hypothesized that the skull protects the brain from oxidative
damage during extended PMIs (Hynd et al., 2003), which
is of interest given that 5hmC, 5fC, and 5caC are oxidative
products of 5mC. Although initial reports confirm that lengthy
PMIs may not alter epigenetic landscapes, their effects on DNA
demethylation products have yet to be determined. In this
report, we provide evidence that these cytosine modifications are
stable during post-mortem intervals and can reflect the actual
status of 5mC and 5hmC at the time of death in post-mortem
tissue.
MATERIALS AND METHODS
Experimental Design
Sprague Dawley rats (Charles River Laboratories International,
Wilmington, MA, USA) were selected as a model to test
the effects of PMI. Young adult rats (60-days old, n = 16)
were caged independently and allowed to habituate to the
environment for one week. The animals were then sacrificed
by gas asphyxiation and left in open air for various PMIs.
In order to mimic natural biological circumstances, the rats
were subjected, at room temperature, to PMIs ranging from
0 to 96 h, and a fixed time of 24 h at 4◦C to simulate the
time a human donor typically spends in the morgue before
tissue collection. Eight different PMI time points (n = 2 per
PMI) were investigated: Control (immediate dissection and flash
freezing in isopentane cooled to −50◦C), 0, 6, 12, 24, 48,
72, and 96h (Figure 1). All but the control animals, which
were processed immediately after death with no PMI, were
kept at 4◦C for 24h before processing. After processing, all
samples were stored at −80◦C. This study was approved by the
Douglas Hospital Research Centre’s Animal Research Committee
(#04/15).
DNA Extraction for LC–MS, ELISA, and
5hmC Capture
DNA was extracted from rat brain using a
phenol:chloroform:isoamyl extraction protocol. Briefly, 40 mg
of frozen tissue was homogenized in lysis buffer and incubated
overnight with proteinase K. DNA was treated with RNAse A
prior to phenol:chloroform:isoamyl extraction. NanoDrop 2000
spectrophotometer and Quant-IT PicoGreen (Thermo Scientific,
Waltham, MA, USA, Cat. #: P7589) were used to assess the DNA
purity and concentration.
Liquid Chromatography–Mass
Spectrometry (LC–MS)
One microgram of genomic DNA per sample was incubated with
5 units of the DNA Degradase Plus (Zymo Research, Irvine, CA,
FIGURE 1 | Experimental design showing post-mortem intervals (PMIs) from 0 to 96 h. All animals (n = 16, 2 per condition) were sacrificed at the same time.
Brains from the control animals (CTRL) were dissected immediately following sacrifice, flash frozen and stored at −80◦C. After being sacrificed, animals from the 0 h
time point were placed immediately at 4◦C for 24 h, followed by brain dissection and storage at −80◦C. The remaining animals were left at room temperature for the
designated PMIs (6–96 h), followed by 24 h at 4◦C. Brains were dissected and stored at −80◦C thereafter.
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USA, Cat.# E2021) enzyme overnight at 37◦C. Samples were
loaded and separated on a homemade reversed-phase column
(150 µm i.d. × 150 mm), with a gradient going from 0 to
10% B in 18 min and a 600 nl/min flow rate on an Easy nLC
(Thermo Scientific, Waltham, MA, USA) connected to a Fusion
Orbitrap (Thermo Scientific, Waltham, MA, USA). MS analysis
consists of a PRM acquisition method for C, mC, and hmC,
consisting, respectively, of a SIM scan at m/z at 228.1, 242.1, and
256.1, followed by tandem mass spectra for each transition at a
normalized collision energy (NCE) of 30%. Ion chromatograms
TABLE 1 | Primer sequences for qRT-PCR following 5hmC capture.
Target Forward primer Reverse primer Length (bp)
Ifg2–1 TTGTGGGCTCCATTGAGTTT ACGGCGTCCGTCTCATTAT 118
Ifg2–2 AAACCCTCCTGTTTTTGCAG ACACCCCTATCCCCAAGAGT 135
Ifg2–3 ACTCTTGGGGATAGGGGTGT AAGCACCAACATCGACTTCC 104
Ifg2–4 GGAAGTCGATGTTGGTGCTT CAAACTGAAGCGTGTCAACAA 114
h19–1 GGGCAGTGAAGGTGTAGCTG GCCTCGCTCTCTAAACCTTTT 124
h19–2 TCGCTGCACTGACCTTCTAA CCGAGACGATGTCTCCTTTG 119
h19–3 GAAAGGCAGGACAGTTAGCAA CAGCCCTGCACCTCTTCTAT 129
FIGURE 2 | Global levels of 5mC and 5hmC show no differences across increasing PMI. (A,B) Global levels of 5mC (A) and 5hmC (B) were measured by
LC/MS (H = 10.36; p = 0.1690 and H = 11.88; p = 0.1044, respectively). (C,D) LC/MS results for 5mC (C) and 5hmC (D) were validated using ELISA-based
quantification (H = 10.28; p = 0.1733 and H = 7.103; p = 0.4182, respectively). Dunn’s multiple comparisons tested individual PMIs against the CTRL. n = 2 per
PMI. Significance set at p < 0.05.
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were extracted for fragment ions m/z 112.0505, 126.0661, and
142.0611.
ELISA-Based Global 5mC and 5hmC
Quantification
One hundred nanograms of DNA per sample were denatured,
as per manufacturer’s guidelines, and added to Zymo Research
ELISA kits (Zymo Research, Irvine, CA, USA, Cat. # D5325 and
D5425 for 5mC, and 5hmC, respectively). Primary and secondary
antibodies were added following manufacturer’s guidelines.
Plates were allowed to develop at room temperature and
absorbance was read at 405nm for both kits.
DNA Extraction for EpiTYPER
DNA was extracted from 40 mg of frozen rat brain tissue
using the Qiagen DNeasy Blood & Tissue kit (Qiagen
Inc., Toronto, ON, Canada, Cat.# 69506). NanoDrop 2000
spectrophotometer (Thermo Scientific, Waltham, MA, USA)
was used to assess the purity and concentration of the
DNA. DNA was bisulfite converted using EpiTect Bisulfite
Kit (Qiagen Inc., Toronto, ON, Canada, Cat.# 59104). Briefly,
DNA was treated with sodium bisulfite, cycling between 95
and 60◦C for 5 h. These conditions result in deamination
of the cytosine into a uracil, except in the presence of
a modified cytosine. The combination of 5mC and 5hmC
was assessed using the EpiTYPER service platform from the
McGill University Genome Quebec Innovation Centre. The
Centre designed the primers for h19 and Igf2, which are
maternally and paternally imprinted regions, respectively, using
EpiDesigner. Regional coordinates for h19 and Igf2 were chr1:
222,641,272–222,641,531 and chr1: 202,911,352–202,911,723,
respectively.
5hmC Capture
5hmC from rat brain DNA was captured using selective chemical
labeling, as previously described (Song et al., 2011). Final
concentrations of captured DNA were measured using Qubit
Fluorometric Quantitation (Life Technologies, Carlsbad, CA,
USA). Site-specific levels of 5hmC were assessed by quantitative
real-time polymerase chain reaction (qRT-PCR) on Applied
Biosystems’ 7900HT Fast Real-Time PCR System (Applied
Biosystems, Carlsbad, CA, USA). SYBR green primers were tiled
across the same h19 and Igf2 loci as the EpiTYPER analyses.
Primer sequences are listed in Table 1. The 9600 emulation
thermal cycle protocol was: 50◦C for 2 min, 95◦C for 10 min,
and 40 repetitions of 95◦C for 15 s and 60◦C for 1 min. The
data were extracted by relative quantification using Applied
Biosystems’ SDS 2.4 and RQ Manager 1.2.1 software. Data were
normalized using input DNA, which represents non-captured
sheared DNA.
Statistical Analyses
All statistical tests were performed using GraphPad Prism 6.
The specifics of each test are outlined in the results section.
Statistical significance was set at p < 0.05. Error bars represent
Mean± S.E.M.
RESULTS
DNA cytosine methylation is considered a highly stable
nucleotide modification that remains unchanged over time
(Barrachina and Ferrer, 2009), largely due to the strong covalent
bond between the methyl group and the 5′ carbon of cytosine.
Indeed DNA methylation was previously shown to withstand
various changes in pH with no differences observed even
in extremes (Ernst et al., 2008). Since this covalent bond
is maintained during cytosine oxidation, the stability of the
demethylation intermediates should also remain stable across
increasing PMI. To evaluate this hypothesis, the primary cytosine
modifications, 5mC and 5hmC, were tested both globally and at
specific loci for 8 different PMIs.
Global Levels of 5mC and 5hmC
We first explored global levels of each cytosine modification
by LC–MS. Two subjects per time point were run in
duplicate. Kruskal–Wallis ANOVA followed by Dunn’s multiple
comparison tests showed no effect of PMI on global 5mC
(H = 10.36; p = 0.1690) or 5hmC (H = 11.88; p = 0.1044)
levels (Figures 2A,B). As an alternative method to detect global
levels, we used absorbance-based ELISA kits with antibodies
specific to 5mC and 5hmC. Kruskal–Wallis ANOVA followed by
Dunn’s multiple comparison tests confirmed that increasing PMI
does not alter global 5mC (H = 10.28; p = 0.1733) or 5hmC
(H = 7.103; p= 0.4182) levels (Figures 2C,D).
Site-Specific Levels of 5mC and 5hmC
We also wanted to know whether 5mC and 5hmC show
loci-specific stability. To do so, we investigated two genes,
h19 and Igf2, both of which are known to undergo parental
imprinting in humans and rats. Bisulfite conversion followed
by EpiTYPER was used to assess the combination of 5mC and
5hmC, while levels of 5hmC were assessed using 5hmC capture
followed by qRT-PCR. Two-way ANOVA showed no significant
interaction between CpG cytosine modification and PMI for
the h19 (F(35,42) = 0.3603; p = 0.9987) (Figure 3A) or Igf2
(F(42,49) = 0.6150; p = 0.9453) (Figure 3B) loci, while Dunnett’s
multiple comparison test showed no difference in CpG cytosine
modification between the control and increasing PMIs. Similarly,
two-way ANOVA also showed no significant interaction between
locus-specific 5hmC and PMI for h19 (F(14,24) = 0.07283;
p > 0.9999) (Figure 4A) or Igf2 (F(21,32) = 0.1145; p > 0.9999)
(Figure 4B), while Dunnett’s multiple comparison test showed
no difference in 5hmC levels between the control and increasing
PMIs.
DISCUSSION
The use of post-mortem tissue is an invaluable resource to
investigate biological processes in the brain. However, using
tissue collected postmortem may present certain limitations.
Of great interest is how the PMI may affect the quality of
tissue and our ability to generate reliable data. As cytosine
modifications are a focus of much of the research in the field
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FIGURE 3 | Site-specific levels of cytosine modifications across the h19 and Igf2 loci remain stable with increasing PMI. EpiTYPER was used to analyze
the percent of methylation + hydroxymethylation at the h19 (A) and Igf2 (B) loci (F(35,42) = 0.3603; p = 0.9987 and F(42,49) = 0.6150; p = 0.9453, respectively).
Dunnett’s multiple comparisons tested %5mC + 5hmC of individual PMIs against the CTRL for each CpG. n = 2 per PMI. Significance set at p < 0.05.
of epigenetics, it is of paramount importance to understand
whether PMI alters the DNA demethylation pathway. In this
study, we show that global and loci-specific levels of cytosine
modifications remain largely unchanged across increasing PMIs.
This data lends weight to the notion that cytosine modifications
are stable and can be accurately assessed in postmortem
research.
Our findings are reassuring considering the longevity of DNA
integrity after death. Interestingly, it was recently determined
that the half-life of DNA is 521 years (Allentoft et al., 2012).
Although this study referred to a specific mitochondrial DNA
sequence from fossils, research suggests a distinct stability of
DNA, especially from the brain (Bar et al., 1988). These findings
are pertinent when considering the potential for oxidative
damage occurring during death. Since oxidation of 5mC results
in downstream modifications to cytosine, it may be presumed
that these modifications are susceptible to degradation following
death. Our results counter this presumption and show an
impressive stability of the tested cytosine modifications. Our
findings are more in line with the proposal that cortical DNA
is particularly stable, as it is protected by the skull from
environmental contamination (Bar et al., 1988; Hynd et al.,
2003).
This study is not without several methodological limitations.
To best mimic human conditions, Sprague Dawley rats were
selected as a model for PMI as their genetic backgrounds are
similar to humans. Although it would have been ideal to also
take into account the effects of agonal conditions, such as
long hospital stays, comas, or hypoxic states, subjecting the
rats to these antemortem conditions would not be ethical.
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FIGURE 4 | Site-specific levels of 5hmC across the h19 and Igf2 loci remain stable with increasing PMI. 5hmC capture by selective chemical labeling was
used to analyze relative 5hmC levels (sample Ct/Input Ct) at the h19 (A) and Igf2 (B) loci (F(14,24) = 0.07283; p > 0.9999 and F(21,32) = 0.1145; p > 0.9999,
respectively). Dunnett’s multiple comparisons tested relative 5hmC levels of individual PMIs against the CTRL for each amplicon within the region of interest. n = 2
per PMI. Significance set at p < 0.05.
In addition, when studying brain tissue exposed to long
post-mortem intervals, distinguishing brain anatomy is quite
challenging. In this study, we used similar sections from the
frontal region of each brain, although the exact region cannot
be reported. Furthermore, although bisulfite conversion does
not distinguish between 5mC and 5hmC (Huang et al., 2010)
for site-specific methylation analysis, we saw no differences
in 5hmC through the accompanying 5hmC capture. As such,
5hmC is unlikely to represent a significant variation in the
EpiTYPER analyses, thereby making them generalizable to 5mC
as well. Another potential limitation was our inability to quantify
5fC or 5caC, however, given the very low abundance of these
demethylation intermediates across tissue types (Ito et al.,
2011), this should not come as a surprise. In fact, previous
studies utilized thymine DNA glycosylase (TDG) knockdowns or
knockouts to increase the levels of 5fC and 5caC (Shen et al.,
2013; Song et al., 2013; Wu et al., 2014; Neri et al., 2015).
Nevertheless, given the inherent stability of DNA, along with
the stability of 5mC and 5hmC, we hypothesize that 5fC and
5caC would not be affected by increasing PMI. To confirm this
hypothesis, further studies could first create a TDG knockout
animal, then continue with the PMI protocol described in this
manuscript.
Taken together, the results presented here may enhance
confidence in future research studying cytosine modifications in
post-mortem samples. Undoubtedly, the continuing debate
regarding the function of these modifications as DNA
demethylation intermediates (He et al., 2011; Shen et al.,
2013) or as a transcriptional regulators (Mellen et al., 2012; Lister
et al., 2013; Wen et al., 2014; Gross et al., 2015) will require more
in-depth analyses using post-mortem tissue. Furthermore, the
stability of these modifications across PMIs allows researchers
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to continue elucidating the function of cytosine modifications in
brain-related diseases and disorders.
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